DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Akarca FK, Can O, Yalcinli S, Altunci YA.
Nivolumab, a new immunomodulatory drug, a new adverse effect; adrenal crisis.
Turk J Emerg Med 2017;
17 (04) 157-159
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.